» Articles » PMID: 21894262

Pneumocystis Jirovecii Pneumonia in Developing Countries

Overview
Journal Parasite
Specialty Parasitology
Date 2011 Sep 7
PMID 21894262
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Pneumocystis pneumonia (PcP) is a serious fungal infection among immunocompromised patients. In developed countries, the epidemiology and clinical spectrum of PcP have been clearly defined and well documented. However, in most developing countries, relatively little is known about the prevalence of pneumocystosis. Several articles covering African, Asian and American countries were reviewed in the present study. PcP was identified as a frequent opportunistic infection in AIDS patients from different geographic regions. A trend to an increasing rate of PcP was apparent in developing countries from 2002 to 2010.

Citing Articles

Global prevalence, mortality, and main characteristics of HIV-associated pneumocystosis: A systematic review and meta-analysis.

Ahmadpour E, Valilou S, Ghanizadegan M, Seyfi R, Hosseini S, Hatam-Nahavandi K PLoS One. 2024; 19(3):e0297619.

PMID: 38526997 PMC: 10962827. DOI: 10.1371/journal.pone.0297619.


Molecular Study of in Respiratory Samples of HIV Patients in Chile.

Iturrieta-Gonzalez I, Chahin C, Cabrera J, Concha C, Olivares-Ferretti P, Briones J J Fungi (Basel). 2024; 10(2).

PMID: 38392789 PMC: 10889964. DOI: 10.3390/jof10020117.


Public Health Research Priorities for Fungal Diseases: A Multidisciplinary Approach to Save Lives.

Smith D, Gold J, Benedict K, Wu K, Lyman M, Jordan A J Fungi (Basel). 2023; 9(8).

PMID: 37623591 PMC: 10455901. DOI: 10.3390/jof9080820.


Updated estimated incidence and prevalence of serious fungal infections in Trinidad and Tobago.

Edwards R, Boyce G, Alastruey-Izquierdo A, Denning D IJID Reg. 2022; 1:34-40.

PMID: 35757825 PMC: 9216327. DOI: 10.1016/j.ijregi.2021.09.007.


Prognostic factors and clinical efficacy of second-line treatments of Pneumocystis jirovecii pneumonia for non-HIV patients after first-line treatment failure.

Liu A, Sun R, Cao G, Liu X, Zhu H, Yang J BMC Infect Dis. 2022; 22(1):546.

PMID: 35701759 PMC: 9199170. DOI: 10.1186/s12879-022-07523-y.


References
1.
Chernilo S, Trujillo S, Kahn M, Paredes M, Echevarria G, Sepulveda C . [Lung diseases among HIV infected patients admitted to the "Instituto Nacional del Torax" in Santiago, Chile]. Rev Med Chil. 2005; 133(5):517-24. DOI: 10.4067/s0034-98872005000500002. View

2.
Kumarasamy N, Solomon S, Flanigan T, Hemalatha R, Thyagarajan S, Mayer K . Natural history of human immunodeficiency virus disease in southern India. Clin Infect Dis. 2002; 36(1):79-85. DOI: 10.1086/344756. View

3.
Bava A, Cattaneo S, Bellegarde E . Diagnosis of pulmonary pneumocystosis by microscopy on wet mount preparations. Rev Inst Med Trop Sao Paulo. 2002; 44(5):279-82. DOI: 10.1590/s0036-46652002000500009. View

4.
Wakefield A, Stewart T, Moxon E, Marsh K, Hopkin J . Infection with Pneumocystis carinii is prevalent in healthy Gambian children. Trans R Soc Trop Med Hyg. 1990; 84(6):800-2. DOI: 10.1016/0035-9203(90)90087-u. View

5.
St John M, Kumar A . Mortality among HIV-infected paediatric patients in Barbados. West Indian Med J. 2003; 52(1):18-22. View